CEBPA and acute myeloid leukemia: In conclusion, our data show that elevated CEBPA binding to the G2DHE, driven by the hypermorphic effect of CebpaNT, increases TET2-mediated demethylation of the Gata2 promoter, which leads to elevated Gata2 levels in CebpaDM AML.